WO2005034873A3 - A method for reducing anti-neoplastic agent induced side-effects - Google Patents

A method for reducing anti-neoplastic agent induced side-effects Download PDF

Info

Publication number
WO2005034873A3
WO2005034873A3 PCT/US2004/033227 US2004033227W WO2005034873A3 WO 2005034873 A3 WO2005034873 A3 WO 2005034873A3 US 2004033227 W US2004033227 W US 2004033227W WO 2005034873 A3 WO2005034873 A3 WO 2005034873A3
Authority
WO
WIPO (PCT)
Prior art keywords
effects
neoplastic agent
induced side
reducing anti
agent induced
Prior art date
Application number
PCT/US2004/033227
Other languages
French (fr)
Other versions
WO2005034873A2 (en
Inventor
Mine Kinoshita
Hiroshi Kushida
Original Assignee
Smithkline Beecham Corp
Mine Kinoshita
Hiroshi Kushida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Mine Kinoshita, Hiroshi Kushida filed Critical Smithkline Beecham Corp
Publication of WO2005034873A2 publication Critical patent/WO2005034873A2/en
Publication of WO2005034873A3 publication Critical patent/WO2005034873A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Abstract

The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
PCT/US2004/033227 2003-10-09 2004-10-07 A method for reducing anti-neoplastic agent induced side-effects WO2005034873A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51002703P 2003-10-09 2003-10-09
US60/510,027 2003-10-09

Publications (2)

Publication Number Publication Date
WO2005034873A2 WO2005034873A2 (en) 2005-04-21
WO2005034873A3 true WO2005034873A3 (en) 2005-12-08

Family

ID=34435051

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/033227 WO2005034873A2 (en) 2003-10-09 2004-10-07 A method for reducing anti-neoplastic agent induced side-effects

Country Status (1)

Country Link
WO (1) WO2005034873A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200804347A (en) 2006-01-10 2008-01-16 Janssen Pharmaceutica Nv Urotensin II receptor antagonists
JP5379000B2 (en) 2006-07-31 2013-12-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Urotensin II receptor antagonist
PA8782701A1 (en) 2007-06-07 2009-01-23 Janssen Pharmaceutica Nv UROTENSIN II RECEIVER ANTAGONISTS
US9079896B2 (en) 2008-08-02 2015-07-14 Janssen Pharmaceutica Nv Urotensin II receptor antagonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090348A1 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002090348A1 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides

Also Published As

Publication number Publication date
WO2005034873A2 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
NO20052493D0 (en) Selected CGRP antagonists, processes for their preparation and their use as pharmaceutical compositions.
WO2004014322A3 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
WO2006068826A3 (en) 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
WO2004074244A3 (en) Pyrimidine compounds
IL168056A0 (en) Selected cgrp antagonists, method for production and use thereof as medicament
WO2004096798A3 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
IL181301A0 (en) Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
IL164798A0 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
WO2005110994A3 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
WO2006010423A3 (en) Azaindole inhibitors of mtp and apob
WO2003095455A3 (en) Substituted pyrazolopyrimidines
ZA200409321B (en) Oil soluble compositions.
WO2007030361A3 (en) Benzimidazole thiophene compounds as plk inhibitors
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
MXPA03010158A (en) Sulfonamides.
WO2005016883A3 (en) Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
WO2008048121A3 (en) Macrocyclic cysteine protease inhibitors and compositions thereof
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
WO2004092100A8 (en) Indene derivatives as pharmaceutical agents
WO2005030209A8 (en) Pyridine derivatives and use thereof as urotensin ii antagonists
NO20065898L (en) 1-heterocyclyl-1,5-dihydro-pyrido [3,2-b] indole-2-ones
WO2004112771A8 (en) Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
WO2006023586A3 (en) Guanylhydrazone compounds, compositions, methods of making and using
WO2005034873A3 (en) A method for reducing anti-neoplastic agent induced side-effects
WO2006055663A3 (en) The use of novel antibacterial compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase